Download PDF
Thromb Haemost 1978; 39(03): 564-573
DOI: 10.1055/s-0038-1646729
Original Article
Schattauer GmbH Stuttgart

Preparation and Evaluation of an Antiserum to the Carboxymethylated Aα Chain of Human Fibrinogen

J A Conkie
The Department of Haematology, Glasgow Royal Infirmary, Castle Street, Glasgow, Great Britain
,
J F Davidson
The Department of Haematology, Glasgow Royal Infirmary, Castle Street, Glasgow, Great Britain
› Author Affiliations
Further Information

Publication History

Received 14 July 1977

Accepted 05 November 1977

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Antiserum to the carboxymethylated Aα chain of human fibrinogen has been produced in rabbits and its reactions investigated in a double diffusion system. The antiserum reacts with the carboxymethylated Aα chains, but not with carboxymethylatedγ chains, nor with carboxymethylated Bβ chains, provided that the antiserum had been absorbed with carboxymethylated Bβ chains.

The antiserum also reacts with Aα chains in the whole fibrinogen molecule, either in plasma or in the purified form, and spur formation was observed when intact fibrinogen was compared with high solubility fibrinogen, which contained little or no intact Aα chain.

 

  • References

  • 1 BlombåCK B, BlombåCK M. 1956; Purification of human and bovine fibrinogen. Arkiv för Kemi 10: 415
    PubMedGoogle Scholar
  • 2 BlombåCK B, BlombåCK M, Finkbeiner W, Holmgren A, Kowalska-LOTH B, Olovson G. 1974; Enzymatic reduction of disulfide bonds in fibrin-ogen by the thioredoxin system. I. Identification of reduced bonds and studies on reoxidation process. Thrombosis Research 4: 55
    CrossrefPubMedGoogle Scholar
  • 3 BlombåCK M, BlombåCK B, Holmqvist H. 1976; Immunological characterization of early fibrionogen degradation products. Radioimmunoassay of fragments released from the Aα-chain of fibrinogen. Thrombosis Research 8: 567
    CrossrefPubMedGoogle Scholar
  • 4 Brummel MC, Montgomery R. 1970; Acrylamide gel electrophoresis of the S-sulfo derivatives of fibrinogen. Analytical Biochemistry 33: 28
    CrossrefPubMedGoogle Scholar
  • 5 GÅrdlund B. 1975. Immunological cross reaction between chains of human fibrinogen. Vth Congress of the International Society on Thrombosis and Haemostasis; Paris: July 1975: 62
    Google Scholar
  • 6 Gårdlund B. 1977; Human fibrinogen-immunological properties of the subunits. Immunochemistry 14: 405
    CrossrefPubMedGoogle Scholar
  • 7 Gårdlund B, Kowalska-loth B, GröNDAHL NJ, BlombåCK B. 1972; Plasmic degradation products of human fibrinogen. I Isolation and characterization of fragments E and D and their relation to “disulfide knots”. Thrombosis Research 1: 371
    CrossrefPubMedGoogle Scholar
  • 8 Gollwitzer R, Hahn E, Lotter H, Nowack H, Timpl R. 1976; Immunochemistry of bovine fibrinogen. II. Analysis by immunoadsorption of the antibody response against three large cyanogen bromide peptides. Immunochemistry 13: 339
    CrossrefPubMedGoogle Scholar
  • 9 Gollwitzer R, Hahn E, Nowack H, Timpl R. 1975; Immunochemistry of bovine fibrinogen. I. Immunogenic activity and diversity of antigenic determinants of reduced and carboxymethylated α, β and γ chains. Immunochemistry 12: 893
    CrossrefPubMedGoogle Scholar
  • 10 Gollwitzer R, Timpl R. 1975; Isolation and immunological characterization of a disulfide loop region in human fibrinogen a chain. FEBS Letters 58: 269
    CrossrefPubMedGoogle Scholar
  • 11 Gollwitzer R, Timpl R, Becker U, Furthmayr H. 1972; Chemical and immunological properties of reduced and alkylated polypeptide chains of bovine fibrinogen. European Journal of Biochemistry 28: 497
    CrossrefPubMedGoogle Scholar
  • 12 Harfenist EJ, Lauer RC, Canfield RE, Nossel HL. 1975. Isolation, characterization and radioimmunoassay of a peptide resulting from limited proteolysis of human fibrinogen by plasmin. Vth Congress of the International Society on Thrombosis and Haemostasis; Paris: July 1975: 408
    Google Scholar
  • 13 Hessel B. 1975; On the structure of the COOH-terminal part of the Aa chain of human fibrinogen. Thrombosis Research 7: 75
    CrossrefPubMedGoogle Scholar
  • 14 Hudry-CLERGEON G, Paturel C, Suscillon M. 1974; Identification d’un complexe (D-D) . . . E dans les produits de dégradation de la fibrine bovine stabilisée par le facteur XIII. Pathologie et Biologie, Suppl 22: 47
    PubMedGoogle Scholar
  • 15 Jamieson GA, Gaffney Jr PJ. 1968; Nature of the high molecular weight fraction of fibrinolytic digests of human fibrinogen. Biochimica et biophysica acta 154: 96
    CrossrefPubMedGoogle Scholar
  • 16 Kowalska-LOTH B, GåRDLUND B, Egberg N, BlombåCK B. 1973; Plasmic degradation products of human fibrinogen. II. Chemical and immunological relation between fragment E and N-DSK. Thrombosis Research 2: 423
    CrossrefPubMedGoogle Scholar
  • 17 Kudryk B, Reuterby J, BlombåCK B. 1974; Immunochemical studies on human fibrinogen and its fragments. Cross-reactivity of NH2-terminal “disulfide knot” and related structures as determined by radioimmunoassay. European Journal of Biochemistry 46: 141
    PubMedGoogle Scholar
  • 18 Lefvert AK, Kudryk B, Murano G, BlombÄCK B. 1974; Immunologic properties of Aachain of human fibrinogen. European Journal of Biochemistry 47: 23
    CrossrefPubMedGoogle Scholar
  • 19 Lotter H, Timpl R. 1975; Antigenic structure of the cyanogen bromide peptide F-CB3 from fibrinogen α-chain. European Journal of Biochemistry 60: 221
    CrossrefPubMedGoogle Scholar
  • 20 Marder VJ, Shulman NR, Carroll WR. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. Journal of Biological Chemistry 244: 2111
    PubMedGoogle Scholar
  • 21 Matthias FR, Heene DL, Wegrzynowicz Z. 1974; Reduction of insolubilized fibrinogen. Thrombosis Research 4: 803
    CrossrefPubMedGoogle Scholar
  • 22 Mcdonagh J, Messel H, MCDONAGH Jr RP, Murano G, Blombåck B. 1972; Molecular weight analysis of fibrinogen and fibrin chains by an improved sodium dodecyl sulfate gel electrophoresis method. Biochimica et biophysica acta 257: 135
    CrossrefPubMedGoogle Scholar
  • 23 Mosesson MW, Finlayson JS, Galanakis DK. 1973; The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis. Journal of Biological Chemistry 248: 7913
    PubMedGoogle Scholar
  • 24 Mosesson MW, Finlayson JS, Umfleet RA, Galanakis D. 1972; Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. Journal of Biological Chemistry 247: 5210
    PubMedGoogle Scholar
  • 25 Mosesson MW, Sherry S. 1966; The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 5: 2829
    CrossrefPubMedGoogle Scholar
  • 26 Murano G, Williams L. 1974; An improved method for the preparative isolation of the S-carboxymethyl derivative chains of human fibrinogen. Preparative Biochemistry 4: 1
    CrossrefPubMedGoogle Scholar
  • 27 Murano G, Wiman B, BlombåCK M, BlombåCK B. 1971; Preparation and isolation of the S-carboxymethyl derivative chains of human fibrinogen. FEBS Letters 14: 37
    CrossrefPubMedGoogle Scholar
  • 28 Nakamura S, Iwanaga S, Suzuki T. 1974; Structural changes of subunit polypeptides of bovine fibrinogen during proteolysis. Biochimica et biophysica acta 336: 86
    CrossrefPubMedGoogle Scholar
  • 29 Nilehn JE. 1967; Split products of fibrinogen after prolonged interaction with plasmin. Thrombosis et Diathesis Haemorrhagica 18: 89
    PubMedGoogle Scholar
  • 30 Nossel HL, Chatpar R, Butler Jr VP, Canfield RE. 1972; Radioimmunoassay of fibrinopeptide B. Blood 40: 955
    PubMedGoogle Scholar
  • 31 Nossel HL, Younger LR, Willner GD, Procupez T, Canfield RE, Butler Jr VP. 1971; Radioimmunoassay of human fibrinopeptide A. Proceedings of the National Academy of Sciences USA 68: 2350
    CrossrefPubMedGoogle Scholar
  • 32 Nussenzweig V, Seligmann M, Grabar P. 1961; Les produits de dégradation du fibrinogène humain par la plasmine. II. Etude immunologique: mise en évidence d’anticorps anti-fibrinogène natif possédant des spécificités différentes. Annales de l’Institut Pasteur 100: 490
    PubMedGoogle Scholar
  • 33 Ouchterlony Ö, Nilsson LÅ. 1973. Immunodiffusion and Immunoelectrophoresis. In: Weir DM. (ed.) Handbook of Experimental Immunology, Vol. 1. Blackwell Scientific Publications; Oxford, London, Edinburgh, Melbourne: chapter 19
    Google Scholar
  • 34 Pizzo SV, Schwartz ML, Hill RL, Mckee PA. 1972; The effect of plasmin on the subunit structure of human fibrinogen. Journal of Biological Chemistry 247: 636
    PubMedGoogle Scholar
  • 35 Plow EF, Edgington TS. 1975; A cleavage-associated neoantigenic marker for a γ chain site in the NH2-terminal aspect of the fibrinogen molecule. Journal of Biological Chemistry 250: 3386
    PubMedGoogle Scholar
  • 36 Plow EF, Hougie C, Edgington TS. 1971; Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. Journal of Immunology 107: 1496
    PubMedGoogle Scholar
  • 37 Soria J, Soria C, Boulard C. 1976; Action sur le fibrinogène humain d’immun-sérums dirigés contre les chaînes dissociées de ce fibrinogène. Pathologie et Biologie Suppl 24: 11
    PubMedGoogle Scholar
  • 38 Timpl R, Hahn E, Gollwitzer R. 1975; Antigenic determinants in the disulfide regions of bovine fibrinogen. European Journal of Biochemistry 51: 617
    CrossrefPubMedGoogle Scholar